CAP’s pattern of gene expression is more similar to that of LC1 with decreases in mRNAs for the lipogenic genes FAS and SCD; SCD is a key regulatory enzyme in triglyceride production, and a decrease in its activity is associated with a variety of beneficial endpoints including attenuation of weight gain and obesity (Jeffcoat, 2007). The gene discussed is SCD; the disease is Obesity.